key: cord-0815746-z0as9jq3
authors: Leong, A.; Cole, J.; Brenner, L. N.; Meigs, J. B.; Florez, J. C.; Mercader, J. M.
title: Cardiometabolic Risk Factors for COVID-19 Susceptibility and Severity: A Mendelian Randomization Analysis
date: 2020-09-01
journal: medRxiv : the preprint server for health sciences
DOI: 10.1101/2020.08.26.20182709
sha: f77c946c97c2ea01dc9b1ee37540bd8a8f86d8b9
doc_id: 815746
cord_uid: z0as9jq3

Importance: Early epidemiological studies report associations of diverse cardiometabolic conditions especially body mass index (BMI), with COVID-19 susceptibility and severity, but causality has not been established. Identifying causal risk factors is critical to inform preventive strategies aimed at modifying disease risk. Objective: We sought to evaluate the causal associations of cardiometabolic conditions with COVID-19 susceptibility and severity. Design: Two-sample Mendelian Randomization (MR) Study. Setting: Population-based cohorts that contributed to the genome-wide association study (GWAS) meta-analysis by the COVID-19 Host Genetics Initiative. Participants: Patients hospitalized with COVID-19 diagnosed by RNA PCR, serologic testing, or clinician diagnosis. Population controls defined as anyone who was not a case in the cohorts. Exposures: Selected genetic variants associated with 17 cardiometabolic diseases, including diabetes, coronary artery disease, stroke, chronic kidney disease, and BMI, at p<5 x 10-8 from published largescale GWAS. Main outcomes: We performed an inverse-variance weighted averages of variant-specific causal estimates for susceptibility, defined as people who tested positive for COVID-19 vs. population controls, and severity, defined as patients hospitalized with COVID-19 vs. population controls, and repeated the analysis for BMI using effect estimates from UKBB. To estimate direct and indirect causal effects of BMI through obesity-related cardiometabolic diseases, we performed pairwise multivariable MR. We used p<0.05/17 exposure/2 outcomes=0.0015 to declare statistical significance. Results: Genetically increased BMI was causally associated with testing positive for COVID-19 [6,696 cases / 1,073,072 controls; p=6.7 x 10-4, odds ratio and 95% confidence interval 1.08 (1.03, 1.13) per kg/m2] and a higher risk of COVID-19 hospitalization [3,199 cases/897,488 controls; p=8.7 x 10-4, 1.12 (1.04, 1.21) per kg/m2]. In the multivariable MR, the direct effect of BMI was abolished upon conditioning on the effect on type 2 diabetes but persisted when conditioning on the effects on coronary artery disease, stroke, chronic kidney disease, and c-reactive protein. No other cardiometabolic exposures tested were associated with a higher risk of poorer COVID-19 outcomes. Conclusions and Relevance: Genetic evidence supports BMI as a causal risk factor for COVID-19 susceptibility and severity. This relationship may be mediated via type 2 diabetes. Obesity may have amplified the disease burden of the COVID-19 pandemic either single-handedly or through its metabolic consequences.

Results: Genetically increased BMI was causally associated with testing positive for COVID-19 [6, 696 cases / 1,073,072 controls; p=6.7×10 −4 , odds ratio and 95% confidence interval 1.08 (1.03, 1.13) per kg/m 2 ] and a higher risk of COVID-19 hospitalization [3,199 cases/897,488 controls; p=8.7×10 −4 , 1.12 (1.04, 1.21) per kg/m 2 ]. In the multivariable MR, the direct effect of BMI was abolished upon conditioning on the effect on type 2 diabetes but persisted when conditioning on the effects on coronary artery disease, stroke, chronic kidney disease, and creactive protein. No other cardiometabolic exposures tested were associated with a higher risk of poorer COVID-19 outcomes.

Conclusions and Relevance: Genetic evidence supports BMI as a causal risk factor for COVID-19 susceptibility and severity. This relationship may be mediated via type 2 diabetes.

Obesity may have amplified the disease burden of the COVID-19 pandemic either singlehandedly or through its metabolic consequences. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08. 26.20182709 doi: medRxiv preprint KEY POINTS Question: Is there a causal association between cardiometabolic conditions and COVID-19 susceptibility or severity?

Findings: Using two-sample Mendelian randomization of 17 cardiometabolic diseases and traits, only body mass index was found to be causally associated with testing positive for COVID-19 (6,696 cases/ 1,073,072 controls; p=6.7×10 −4 ) and a higher risk of COVID-19 (3, 199 cases/897,488 controls; p=8.7×10 −4 ).

Meaning: Genetic evidence supports BMI as a causal risk factor for COVID-19 susceptibility and severity. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08. 26.20182709 doi: medRxiv preprint

There is high heterogeneity in both susceptibility and severity of SARS-CoV2 infection with clinical severity 1,2 ranging from asymptomatic carriers to life-threatening respiratory failure and death 3 . Epidemiological studies using both retrospective and prospective cohorts of different sizes and from multiple countries have reported evidence that underlying cardiometabolic conditions 4-29 may be associated with an increased risk of severe COVID-19 illness (i.e., hospitalization, intubation, mechanical ventilation or death 30 ) . Coronary artery disease 4-6 , chronic kidney disease 7-12 , obesity 13-17 and type 2 diabetes 8,18-21 have a strong and consistent evidence for association with COVID-19 severity 30 . There is less compelling evidence for cerebrovascular disease 4,22-28 (i.e., stroke) and hypertension 4, 6, [27] [28] [29] leading to severe manifestations of COVID-19. Additional evidence suggests that these cardiometabolic traits may be associated with disease susceptibility 31 ; however without universal testing, this correlation is difficult to prove.

While early reports are crucial to inform clinical decision making and public health policy during a pandemic of a new pathogen, correlative observational data can be plagued by residual confounding. Thus, there remain inherent challenges in drawing causal inferences from these epidemiologic studies. Mendelian Randomization (MR) is an analytic approach that uses human genetic variation known to influence modifiable exposures to examine their causal effect on disease 32 . MR is especially useful for disentangling causal pathways of phenotypically clustered risk factors that are difficult to randomize or prone to measurement error. By identifying causal relationships between cardiometabolic risk factors and COVID-19 susceptibility or severity, we may be able to mitigate their impact on disease risk and avoid spurious conclusions that lead to misinformation or incite unnecessary anxiety. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08. 26.20182709 doi: medRxiv preprint We hypothesize that only some cardiometabolic conditions have a causal relationship with COVID-19 illness or its disease course. Thus, we sought to evaluate the causal associations of 17 cardiometabolic exposures with COVID-19 susceptibility and severity using two-sample MR analyses. Causal effects were estimated from genome-wide association studies (GWAS) summary statistics of these cardiometabolic diseases and related traits and COVID-19related outcomes from the COVID-19 host genetics initiative (https://www.covid19hg.org/) 33 .

We extracted association summary statistics from published large-scale GWAS metaanalysis to generate sets of genetic instruments for 17 cardiometabolic diseases and traits, type 1 diabetes 34 , type 2 diabetes 35 , hemoglobin A1c 36 , fasting glucose adjusted for body mass index (BMI) 36 , fasting insulin adjusted for BMI 36 , BMI 37 , waist-hip ratio 38 , low-density lipoprotein cholesterol 39 , high-density lipoprotein cholesterol 39 , triglycerides 39 , systolic blood pressure 40 , diastolic blood pressure 40 , creatinine-based estimated glomerular filtration rate (eGFR) 41 , chronic kidney disease 41 coronary artery disease 42 , any stroke 43 , and c-reactive protein 44 (CRP), a non-specific biomarker of inflammation that can be elevated in people with high cardiometabolic risk. We used genetic variants associated with these exposures at genomewide significance (p<5x10 -8 ) and excluded those that were not represented in the COVID-19 outcome GWAS datasets. Using the LD_clumping function, we pruned the list of candidate instruments for linkage disequilibrium (LD; R 2 >0.01) and discarded variants that were within 1-Mb distance from other candidate instruments with a stronger association. Aanalyses were performed using the R package "twosampleMR" v.4.0 45, 46 .

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08. 26.20182709 doi: medRxiv preprint The COVID-19 Host Genetics Initiative is an international genetics collaboration that aims to uncover the genetic determinants of outcomes related to COVID-19 susceptibility and severity 33 . To accomplish this, investigators from around the world assembled individual-level clinical and genetic data and performed individual GWAS. Summary statistics were shared via a cloud-based computing platform, and centralized meta-analysis was performed. Singlevariant association testing were adjusted for age, age 2 , sex, age*sex, genetic ancestry principal components and other study-specific covariates. An allele frequency filter of 0.0001 and an INFO filter of 0.6 was applied to each study prior to meta-analysis with inversevariance weighting. Summary statistics from the third round of GWAS meta-analysis, shared publicly on July 2, 2020, were used to test the 17 sets of genetic instruments against COVID-19 outcomes assembled by the COVID-19 Host Genetics Initiative.

For our two primary analyses, we selected the COVID-19 outcomes with the largest number of cases. For Susceptibility: 1) COVID-19 by RNA PCR, serologic testing, or clinician diagnosis by chart review or ICD-coding (6,696) vs. population controls (N=1,073,072) and for Severity: 2) hospitalization of patients with COVID-19 by RNA PCR, serologic testing, or physician diagnosis (N=3,199) vs. population controls defined as any person who was not a case (i.e., people who tested negative, were never tested, or had an unknown testing status; N=897,488),As controls were not selected based on testing results, specific characteristics, or testing status, they were likely to be representative of the general population.

To determine whether statistically significant results from the primary analyses were consistent across different definitions for COVID-19 susceptibility, severity, and control groups, we performed secondary MR analyses of the four remaining available outcomes. For Susceptibility: 1) COVID-19 positive by RNA PCR, serologic testing, or clinician diagnosis (N=3,523) vs. COVID-19 negative by RNA PCR, serologic testing, or self-report (N=36,634); 2) predicted COVID-19 based on symptoms or COVID-19 positive by self-report (N=1,865) vs. no All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. 

To estimate the causal association of each exposure with each outcome, we performed two-sample MR analyses using the random-effects inverse-variance weighted (IVW) method, whereby genetic variant-outcome coefficients were modeled as a function of genetic variantexposure coefficients weighted by the inverse of the squared genetic variant-outcome standard errors 48 . The use of random effects provides a concise estimation and considers potential heterogeneity among estimates from individual variants 49 . We used p<0.05 / 17 exposures / 2 outcomes = 0.0015 to declare statistical significance with the understanding that this threshold may be conservative as exposures are clinically correlated. We reported causal effect estimates as odds ratios for the outcome per log-odds of binary exposures or unit change of continuous exposures. For BMI, we repeated the analysis using untransformed variables from UK Biobank (http://www.nealelab.is/uk-biobank) to report causal effect estimates per unit change of raw BMI.

An assumption of MR is that instruments do not influence the outcome independently of the risk factor of interest (i.e. non-mediated pleiotropy). We tested this assumption in a series of sensitivity analyses. We used the Weighted Median Estimator (WME) 50 which requires ≥ 50% of All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.26.20182709 doi: medRxiv preprint the contribution to the causal estimate to be from valid instruments; if so, its causal estimate is stable. We then used the MR-Egger regression 51 whereby a linear regression of variantoutcome on variant-exposure coefficients was performed without constraining the intercept to the origin. The slope of the regression line provides the corrected causal estimates even when none of the instruments are valid 51 . Next, we used the mode-based estimate which is consistent when the largest number of similar single-variant MR estimates are derived from valid instruments even when the majority are invalid 52 . If all MR models produce similar causal estimates despite making different assumptions on the validity of instruments, we would be more confident of the robustness of our results 53 . In other sensitivity analysis, we applied MR pleiotropy residual sum and outlier (MR-PRESSO) 54 and leave-one-out analysis to determine whether outliers may be biasing the overall causal estimate. To estimate direct and indirect causal effects of BMI via obesity-related cardiometabolic diseases, CAD, stroke, CKD, type 2 diabetes, and CRP, we performed pairwise multivariable MR wherein we conditioned upon the effects of these exposures with BMI to simultaneously estimate their independent causal effects.

We obtained genetic instruments for the 17 exposures for MR analyses after excluding variants that were in LD (r 2 >0.01) and in close proximity (1 Mb) to other candidate instruments with stronger P-values. Genetic instruments explained between 0.2 to 5.3% of the variance or liability of each exposure (Table 1) . Contributing studies included in these exposure GWAS metaanalyses were predominantly of European ancestry.

Of the 17 cardiometabolic exposures, only BMI was found to be causally associated with All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.26.20182709 doi: medRxiv preprint COVID-19 susceptibility and severity even after accounting for multiple testing (Figure 1 ).

Genetically increased BMI was associated with a higher risk of testing positive for COVID-19 (p=6.7×10 −4 ) and a higher risk of COVID-19 hospitalization (p=8.7×10 −4 ) compared to population controls using random effects IVW (Figure 1 ). For both outcomes, we identified no heterogeneity of effects (p=0.52; p=0.49,) or outlying genetic variants by the leave-one-out analysis or MR-PRESSO. To obtain interpretable effect estimates, we repeated the analysis using beta estimates of raw BMI from UK Biobank 55 Table 1 ).

To determine whether the causal effect of BMI was mediated through obesity-related cardiometabolic diseases, we performed pairwise multivariable MR of BMI with each of the cardiometabolic diseases, type 2 diabetes, chronic kidney disease, coronary artery disease, any stroke, and CRP. The direct effects of BMI on the two COVID-19 outcomes were abolished upon conditioning on the genetic effects of type 2 diabetes (p>0.05). Adjusting for the genetic effects on the other diseases did not attenuate the direct effect of BMI (p<0.05, Supplemental Table 2) While none of the other cardiometabolic exposures was found to increase COVID-19 susceptibility or severity, we found a borderline association between having a higher genetic predisposition to T1D with a lower risk of testing positive for COVID-19 and hospitalization vs. population controls, though the associations were not statistically significant after accounting for All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.26.20182709 doi: medRxiv preprint multiple testing (Supplemental Table 3 ).

Cardiometabolic diseases have been identified to be risk factors for COVID-19 illness 30 .

Since risk factors may be only correlated, and not causally related, with outcomes of interest, it is paramount to assess causality to inform preventive strategies. Using two-sample MR, we found that genetically increased BMI was the only risk factor for COVID-19 susceptibility and severity among the 17 cardiometabolic diseases and traits tested, whereby the odds of testing positive for COVID-19 was 8% higher per kg/m 2 increased in BMI and the odds of hospitalization with COVID-19 was 12% higher per kg/m 2 increase in BMI than the general population. Our MR findings support the multiple epidemiologic studies that have reported a strong and robust association between obesity and COVID-19 illness [13] [14] [15] [16] [17] . Adjusting for the genetic effect of type 2 diabetes obliterated the direct causal effect of BMI, suggesting that type 2 diabetes may be a mediator in the causal association of BMI and COVID-19 illness. By understanding causality, we can aim to modify causal exposures for the purpose of mitigating disease risk.

Apart from BMI, the other cardiometabolic exposures tested are unlikely to play a key causal role in contracting COVID-19 or worsening the illness. Observational correlations of cardiometabolic conditions with COVID-19 outcomes may be partly due to clinical clustering with obesity. It is noteworthy that correlational risk factors can still have clinical utility in identifying at-risk patients even if causality is refuted. However, if preventive efforts only target correlated, but not causal, risk factors, disease risk may not be reduced. We found a negative trend between a higher genetic predisposition for type 1 diabetes and a lower risk of hospitalization and testing positive for COVID-19. A negative association with COVID-19 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.26.20182709 doi: medRxiv preprint outcomes could be observed if people with underlying medical conditions were more likely than the general population to undergo testing for COVID-19 and receive a negative test result, made concerted efforts at reducing their risk of viral exposure in response to public health messaging, or were encouraged by health professionals to recuperate at home and not come to the hospital when ill with mild viral symptoms. We could speculate that the autoimmune nature of type 1 diabetes provides protection compared to the general population. Additionally, it is noteworthy that people with T1D, unlike T2D, do not generally have higher BMI than the general population.

More investigation is needed to further understand the cause of this negative association.

Our study had limitations. The variances explained in the exposures by genetic instruments were modest, though well within the ranges that were typical for complex traits. The use of weak genetic instruments could have limited our ability to detect subtle causal associations and does not exclude the possibility of modest effects. It is also possible that, with larger sample sizes, the association of other cardiometabolic exposures with COVID-19 outcomes may become significantly significant and confidence intervals would narrow around true estimates. Additionally, our analysis did not factor non-linear exposure-outcome relationships. The causal estimates by MR-Egger were not as compelling suggesting that horizontal pleiotropy or other confounding factors could have biased estimates. Yet, MR-Egger is a less efficient estimator than the other methods 50 and is generally considered as only one of several sensitivity analyses used to evaluate the plausibility of findings. In our primary analyses we chose to use controls that were broadly defined as not being a case. Without universal testing, the control group, albeit representative of the general population, could have been contaminated with people who had contracted COVID-19, particularly those with only mild or no viral symptoms (asymptomatic), which would have biases estimates towards the null.

Nevertheless, our results were consistent when using controls that were narrowly defined as people who tested negative for COVID-19. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.26.20182709 doi: medRxiv preprint Obesity contributes to higher levels of circulating proinflammatory adipokines and cytokines 56-61 which may intensify virally induced inflammation, [62] [63] [64] [65] [66] [67] [68] [69] and could contribute to acute respiratory distress syndrome, the main cause of mortality from COVID-19 70, 71 . We did not include critical respiratory illness in the primary analysis because the sample size of cases was small. When larger samples become available, future MR analyses can be performed to clarify whether the causal relationship between BMI and COVID-19 illness extends to critical respiratory illness. While contributing studies to the Host Genetics Initiative did not provide information on self-reported race or ethnicity, most were presumably European and association analyses were adjusted for ancestry PCs. Well-powered studies in people of non-European ancestral origins are critically needed to as ethnic and racial minorities in the U.S. are disproportionately affected by the pandemic 7, 11, 27, [72] [73] [74] . We recognize that the primary social drivers of viral exposure and spread (i.e., crowding within households, wealth and education gaps, working in essential jobs that render social distancing challenging, language barriers, and poor access to healthcare) are likely correlated with, or are themselves, determinants of obesity 75, 76 . Future investigations are required to determine whether addressing these upstream social factors mitigates the impact of obesity on COVID-19 outcomes.

Our study provides genetic evidence that support or refute causality for a plethora of cardiometabolic conditions that can inform preventive strategies aimed at modifying risk of COVID-19 illness. Among the 17 cardiometabolic exposures tested, only BMI was found to be a causal risk factor for COVID-19 susceptibility and severity, which is consistent with multiple epidemiologic studies that have reported an association between obesity and COVID-19 illness.

We conclude that obesity may have amplified the disease burden of the COVID-19 pandemic either single-handedly or through its metabolic consequences. To the extent that obesity is a modifiable risk factor with a strong environmental component, public health measures that aim All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08. 26.20182709 doi: medRxiv preprint to diminish the societal obesity burden could be incorporated into an effective preventive strategy for COVID-19 outcomes. Similarly, preventive measures that increase the risk of obesity (e.g. limitation of access to open spaces for exercise) should be viewed with caution.

Future research is required to understand the mechanisms through which obesity increases the risk of COVID-19 outcomes, and whether obesity-related conditions are along the causal pathway. Our study has shown how large-scale genotype-phenotype summary data rapidly assembled during a pandemic and made freely accessible to the research community can accelerate research with immediate and direct application to clinical practice and public health messaging.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.26.20182709 doi: medRxiv preprint

None of the authors declare potential conflicts of interests relevant to this manuscript.

The 

Drs. Aaron Leong and Josep M. Mercader had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

We thank all the genetics consortia and the COVID-19 Host Genetics Initiative for making summary statistics publicly accessible for this analysis. As supplemental information, we acknowledge the contribution of the studies in the COVID- 19 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.26.20182709 doi: medRxiv preprint Where available, we used European-specific effect estimates in the MR analysis. Sample sizes were the maximum number indicated in the published manuscript. Estimated variance explained by genetic instruments was a sum of estimated variance explained by each variant calculated from reported Pvalues, sample sizes, and proportion of cases and controls using the TwoSampleMR R functions get_r_from_lor() and get_r_from_pn().

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. .

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. The New England journal of medicine

Presumed Asymptomatic Carrier Transmission of COVID-19

No association between interleukin-18 levels and risk of cardiovascular disease: A Mendelian randomization study

Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Covid-19 and Kidney Transplantation

Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California

Acute kidney injury in patients hospitalized with COVID-19

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19

High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation

Association of Obesity with Disease Severity Among Patients with Coronavirus Disease

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

Prevalence and impact of diabetes among people infected with SARS-CoV-2

Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, metaanalysis, and meta-regression

15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

Characteristics Associated with Hospitalization Among Patients with COVID-19

OpenSAFELY: factors associated with COVID-19 death in 17 million patients

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19

Who is most likely to be infected with SARS-CoV-2? The Lancet Infectious Diseases

Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects

The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

Fine-mapping type 2 diabetes loci to singlevariant resolution using high-density imputation and islet-specific epigenome maps

The Trans-Ancestral Genomic Architecture of Glycaemic Traits

Genetic studies of body mass index yield new insights for obesity biology

New genetic loci link adipose and insulin biology to body fat distribution

Discovery and refinement of loci associated with lipid levels

Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

A catalog of genetic loci associated with kidney function from analyses of a million individuals

Association analyses based on false discovery rate implicate new loci for coronary artery disease

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes

Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration

The MR-Base platform supports systematic causal inference across the human phenome

Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes

Real-time tracking of self-reported symptoms to predict potential COVID-19

Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors

A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization

Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator

Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression

Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption

Using a two-sample Mendelian randomization design to investigate a possible causal effect of maternal lipid concentrations on offspring birth weight

Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases

The UK Biobank resource with deep phenotyping and genomic data

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

Obesity, inflammation, and atherosclerosis

The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study

Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity

Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets

Type 2 diabetes as an inflammatory disease

Clinical and immunological features of severe and moderate coronavirus disease 2019

The laboratory tests and host immunity of COVID-19 patients with different severity of illness

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes. American journal of physiology Endocrinology and metabolism

SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects

Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation and Cytokine Amplification in COVID-19

Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Acute Respiratory Distress Syndrome

COVID-19 and African Americans

Coronavirus Disease 2019 Case Surveillance -United States

Assessing Differential Impacts of COVID-19 on Black Communities

The spread of obesity in a large social network over 32 years

The Upstream Determinants of Adult Obesity